Saturday, October 1, 2022

Tag: FDA

Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial

NSI-566 to be tested in patients with chronic spinal cord injury ROCKVILLE, Md., Jan. 14, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it...

UM’s Miami Project gets FDA approval for clinical paralysis trial

The FDA’s go-ahead makes The Miami Project’s clinical trial to aid against spinal cord injury the only one in the United States. The Miami Project...

Lyrica Approved for Spinal Neuropathic Pain

The Food and Drug Administration has approved the use of Lyrica for the management of neuropathic pain associated with chronic, debilitating spinal cord injuries....

InVivo Therapeutics Protects And Regenerates The Spinal Cord Resulting in Functional Improvement Below the...

Frank Reynolds, of InVivo Therapeutics (NVIV), says the company is on the verge of unprecedented technology for the treatment of the spinal cord. The...

Promising new therapy could ‘cure’ paralyzed patients

Dr. W. Dalton Dietrich, scientific director of the Miami Project to Cure Paralysis, was in Washington this week seeking U.S. Food and Drug Administration...

Where Does Geron’s Exit from Embryonic Stem Cells Leave the Field?

Given that the firm with the most money has just quit, questions about how to succeed are rampant. Geron, a pioneer in stem cell research...

Working2Walk 2011, Anthony Caggiano (Acorda)

The Challenges of Chondroitinase Development for Spinal Cord Injury

Working2Walk 2011, W. Dalton Dietrich, PhD

The Miami Project to Cure Paralysis is a Center of Excellence at the University of Miami Miller School of Medicine.

Preliminary Human Experiments to Test Safety of Nerve Cell Transplants for Spinal Cord Paralysis

The new approach, currently being studied by the FDA for phase I trials, avoids the problems of immunological rejection and the controversy around the...

A New Hope for Treating Spinal Cord Injury: 5 Points on InVivo Therapeutics’ Technology

InVivo Therapeutics, based in Cambridge, Mass., was founded to focus on research and development of treatment for patients with spinal cord injuries (SCI). Currently,...